藥品名稱 drug name | Magnesium Sulfate (MgSO4) 10% 20ml/amp (Mg: 0.81mEq/ml) 硫酸鎂 |
藥檔狀態 | 使用中 |
成 份 Ingredient | Magnesium Sulfate |
單位含量 | 10% 20ml/amp (Mg: 0.81mEq/ml) |
Dosage Forms | Injection: 10% [100 mg/ml = 0.81 mEq/ml] 20 ml |
顏 色 | |
Color | |
形 狀 | |
Shape | |
劑 型 | 針劑/注射 |
Dose Form | |
大 小 Size | |
標 示 outward | 05 |
廠商名稱 Manufacturer | 信東生技股份有限公司 |
製 造 商 Manufacturer | 信東生技股份有限公司 |
字 號 Product ID | 衛署藥製字第04771號 |
藥理分類 Pharmacologic Category | Nutrients and Nutritional Agents/ Minerals; Neurology/ Anticonvulsants/ Magnesium Sulfate |
作用機轉 Mechanism of action | Magnesium decreases acetylcholine in motor nerve terminals and acts on myocardium by slowing rate of S-A node impulse formation and prolonging conduction time. Magnesium is necessary for the movement of calcium, sodium, and potassium in and out of cells, as well as stabilizing excitable membranes. |
用途/適應症 | 鎂離子補充劑 |
Use |
Treatment and prevention of hypomagnesemia; prevention and treatment of seizures in severe pre-eclampsia or eclampsia, pediatric acute nephritis; treatment of cardiac arrhythmias (VT/VF) caused by hypomagnesemia
|
衛福部核准適用症狀 MOHW approved indications |
子癇症、子癇前症、妊娠毒血症、產科全身麻醉輔助;體內鎂離子缺乏時之補充。
|
常用劑量 | 每天一次,早飯後使用20cc (藥品劑量會因人或病情增減,請依照醫師指示服用。) |
Dose |
☆子癇症、子癇前症、妊娠毒血症、產科全身麻醉輔助: 每日量1~10g I.V.或I.M.,子癇症時頭一次投予4g,後每半小時靜脈注射5mL(0.5g)。
☆體內鎂離子缺乏時之補充: 僅限用於全靜脈營養輸注液調配使用。請勿直接單獨做末梢靜脈內點滴注射。
|
懷孕分級 Pregnancy Risk Factor |
D - [FDA(美國食品及藥物管理局)懷孕分級說明: A:對照試驗無法證實懷孕初期及後期使用會危害胎兒。 B:動物試驗無法證實對胎兒有害,但缺乏人類對照試驗;或動物試驗有副作用報告,但無法證實對懷孕初期及後期之胎兒有害。 C:動物實驗中對胎兒有害但缺乏孕婦對照實驗;或無動物及孕婦試驗。 D:證實對胎兒有害,但疾病對孕婦有生命威脅或較安全藥品無法使用或無效時可使用。 X:證實對胎兒有害,且使用後危害大於可能的益處。孕婦及可能懷孕婦女禁用。]
|
禁忌症 |
禁用於已知對 MgSO4 及其中任何成分過敏之患者。
|
Contraindications |
Hypersensitivity to any component of the formulation; heart block; myocardial damage; IV use for pre-eclampsia/eclampsia during the 2 hours prior to delivery
|
常見副作用 | 腹瀉、嗜睡。 |
Common adverse drug reactions | diarrhea, sleepy. |
Adverse Reactions |
Adverse effects on neuromuscular function may occur at lower concentrations in patients with neuromuscular disease (eg, myasthenia gravis).
|
監測 Monitoring |
Rapid administration: ECG monitoring, vital signs, deep tendon reflexes; magnesium concentrations if frequent or prolonged dosing required particularly in patients with renal dysfunction, calcium, and potassium concentrations; renal function.
|
警語與注意事項 | 請遵照醫師或藥師指示使用;不可口服。 |
Warnings & precautions | |
針劑溶解條件 |
|
針劑稀釋條件 |
|
針劑不相容性 |
|
針劑施打條件 |
靜脈或肌肉注射。
|
針劑保存安定性 |
室溫25℃以下貯存。
|
最近修改日期時間 Updated | 3/13/2018 8:33:09 AM |